51B.F Bioventix PLC

Healthcare Biotechnology Frankfurt Exchange
22.20 EUR
Close of Nov 12, 2026
13.65 23.40
Market cap
EUR 116M
P/E
13.5x
P/B
8.48x
ROE
66.7%
Dividend yield
7.95%
Fundamental score
-

Ratios use the latest price and the fiscal year ending Jun 2026.

Is 51B.F undervalued?

Graham number
Price22.20
Graham value9.86
Premium125.2%

51B.F trades 125.2% above its Graham number.

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Bioventix PLC fundamental analysis

No fundamental analysis for Bioventix PLC yet.

Bioventix PLC stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Bioventix PLC

Bioventix PLC creates, manufactures, and supplies sheep monoclonal antibodies (SMAs) for diagnostic applications worldwide. The company offers a portfolio of purified SMAs for thyroid, vitamin D, cardiac, drugs of abuse, fertility, oncology, and miscellaneous indications; Pyrene (HOP-G) ELISA kit, a sandwich enzyme-linked immunosorbent assay kit for the detection of 1-hydroxypyrene glucuronide in urine samples; and Pyrene (HOP-G) lateral kits, a positive read, semi-quantitat…

Full company profile